Japanese Encephalitis (JE) Vaccine: What Australians Should Know

Japanese Encephalitis Is Rare, But It Can Be Deadly

Japanese Encephalitis (JE) is a mosquito-borne viral infection that affects the brain. While it’s rare in Australia, recent outbreaks in regional areas have raised concern, especially in northern and eastern states, including parts of Victoria. Thankfully, a safe and effective vaccine is available.

If you’re travelling to affected areas or living in rural regions with high mosquito activity, it’s worth understanding your JE vaccine options and whether you might need protection.


What Is Japanese Encephalitis?

Japanese Encephalitis is caused by the JE virus, which is spread through the bite of infected mosquitoes. The virus primarily circulates in pigs and wading birds. Humans are “dead-end” hosts, meaning we don’t spread the virus further, but we can still become severely ill.

Symptoms of JE

Most people infected with JE won’t show symptoms. However, about 1 in 250 people develop:

  • High fever

  • Severe headache

  • Vomiting

  • Confusion or seizures

  • Coma in severe cases

Up to 30% of symptomatic cases can be fatal, and many survivors are left with permanent neurological complications.


Who Should Get the JE Vaccine?

The JE vaccine is recommended for:

  • People living or working in high-risk areas of Australia (e.g. Northern Victoria, Northern Queensland, the Top End of the NT)

  • Travellers to regions in Asia or the Torres Strait where JE is common

  • Laboratory workers handling the JE virus

  • Workers in pig farms or areas with large feral pig populations

Ask your local GP in Bentleigh, Victoria, if you’re eligible for the free JE vaccine under state or federal programs. They can also help determine your individual risk based on travel plans or occupational exposure.


Vaccine Options in Australia

Australia has two JE vaccines available:

  1. Imojev® – A live-attenuated vaccine suitable for adults and children over 9 months.

  2. JEspect® – An inactivated vaccine, given in two doses, preferred for people with weakened immune systems or pregnant women.

Both are safe and well-tolerated. Mild side effects such as soreness at the injection site or a low-grade fever may occur.


Why the JE Vaccine Matters

JE has no specific treatment. Hospital care can support the body while it fights the virus, but prevention is the best protection. The vaccine greatly reduces the risk of infection, especially in high-risk areas.

JE in Australia: A Growing Concern

While JE was once thought to be a travel-only disease, climate conditions and increased mosquito populations have expanded the reach of the virus. Between 2021 and 2023, cases were reported in southern states, including parts of Victoria and NSW. This has prompted public health authorities to offer free vaccination programs in affected regions.


Protecting Yourself and Your Family

Vaccination is the most effective way to prevent JE, but it’s also important to:

  • Use mosquito repellent containing DEET or picaridin

  • Wear long sleeves and pants, especially near wetlands or farms

  • Sleep under mosquito nets when travelling

  • Avoid mosquito-prone areas during peak biting hours (dawn and dusk)


Speak to Your GP in Bentleigh About the JE Vaccine

If you live in Bentleigh or the surrounding South-East Melbourne suburbs, speak to your local GP about whether you or your child should be vaccinated against JE. With recent outbreaks in Victoria, this conversation could be lifesaving.


Key Takeaways

  • Japanese Encephalitis is rare but can be fatal.

  • It’s now present in parts of Victoria and other states.

  • The JE vaccine is safe, effective, and available in Australia.

  • Speak to your GP about your risk and eligibility.

  • Use mosquito protection strategies to further reduce your risk.


References

  1. Victorian Department of Health – Japanese Encephalitis

  2. Australian Immunisation Handbook – Japanese Encephalitis

  3. Hills, S.L. et al. (2013). Japanese Encephalitis: A Review of Clinical Guidelines and Vaccine Use. PubMed ID: 24161909

  4. Moore, C.E. et al. (2023). Emerging threat of JE in southern Australia. PubMed ID: 37037440